Navigation Links
GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
Date:6/6/2008

LONDON, PHILADELPHIA and CAMBRIDGE, Mass., June 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that it has completed its acquisition of Sirtris Pharmaceuticals, Inc. (Sirtris) for approximately USD720 million (or approx. GBP362 million) through a cash tender offer and merger of USD22.50 (or approx. GBP11.33) per share.

Through the acquisition of Sirtris, GSK has significantly enhanced its metabolic, neurology, immunology and inflammation research efforts by establishing a presence in the field of sirtuins, a recently discovered class of enzymes that is believed to be involved in the ageing process.

Sirtris will become part of GSK's Drug Discovery organization, while continuing to operate from laboratories in Cambridge, Massachusetts, as an autonomous drug discovery unit. Christoph Westphal, CEO and Vice Chair of Sirtris, and the management team will continue to lead this autonomous unit.

About GSK

GSK -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information including a copy of this announcement and details of the company's updated product development pipeline, visit GSK at http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... University Orthopedics (UOI) today announced ... of Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. Dr. Bragdon specializes ... Orthopedics and Hand Surgery. , As the leader of comprehensive orthopedic care ...
(Date:3/22/2017)... ... 2017 , ... SNL Insurance and Financial, a Virginia based ... in the greater Hampton Roads area, is embarking on a community charity initiative ... , Each year, hundreds of people living in the South Hampton region are ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... assistance, and related services to families and business owners in the greater Nassau ... the Leukemia & Lymphoma Society. , Every 3 minutes, someone in America is ...
(Date:3/22/2017)... Toronto, CANADA (PRWEB) , ... March 22, 2017 , ... ... Indiegogo today, the Sweep&Stand. The conventional broom was great when it was invented, ... They are the working parents, the social young couple, the empty nesters and ...
(Date:3/22/2017)... ... ... The National Association for Business Resources (NABR) has recently named ... Wellness® companies for 2017. , American Specialty Health (ASH) was honored for ... its employees. ASH is one of only nine other San Diego companies being recognized ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... 2017 A new independent study demonstrates ... proven ultraviolet-C (UV-C) disinfection solution of choice for ... Published in the March issue of ... the peer-reviewed study of UV-C disinfection systems detailed ... Hospital and Rochester General Hospital. According to the ...
(Date:3/22/2017)... NEW YORK , March 22, 2017 ... Electrophysiology (EP) market is growing rapidly due to the ... a report published by Allied Market Research, the global ... is expected to reach $8.271 billion by 2022, with ... cardiology and is used to diagnose abnormal heartbeats or ...
(Date:3/22/2017)... ROCKVILLE, Md. , March 22, 2017 ... that should be important to those following the industry.  This ... point-of-care (POC) RSV test, and the POC testing market ... grow. An Alere subsidiary is facing a legal battle ... Meanwhile, Beckman Coulter launched a new chemistry ...
Breaking Medicine Technology: